Metrion Biosciences’ Sales and Marketing Manager Dr Sophie Rose and Business Development Executive Dr Anca Haralambie will be attending the Nanion Technologies Research Insights Cardiac Safety Symposium taking place on Wednesday 19th and Thursday 20th May 2021 on Hopin.
This 2-day interactive online event is focused on Current Challenges in Safety Pharmacology and Cardiac Physiology, in-silico modelling and Best Practices and Evolvements of Safety Pharmacology Methods.
Date and time:
Start: Wednesday, May 19th (Beginning at 1PM CEST, 7AM EDT )
End: Thursday, May 20th (Beginning at 1PM CEST, 7AM EDT )
Keynote presenters include:
Yasunari Kanda, PhD, Division head, National Institute of Health Sciences Japan
Title: Current status and future perspectives in cardiac safety assessment using human iPSC technology
Day 1 [1:10 PM – 2 PM CEST]
Michael K. Pugsley, PhD, FBPhS, DSP (Cytokinetics)
Title: A 20 Year Journey through the Continuously Evolving Role of Safety Pharmacology in Drug Safety Evaluation
Day 2 [3:10 PM – 4 PM CEST]
Please visit the following link for more information: https://www.nanion.de/en/news/events/upcoming-events/6730-19-05-2021-research-insights-cardiac-safety-meeting-2021.html